Events
News and Upcoming Events
World Vaccine Congress – 2024
Bring Vaccines to Market Faster Trusted Vaccine Industry Partner for Over 20 Years World Vaccine Congress April 1-4, 2024 Washington, D.C. Visit Us at Booth #559 InDevR presents a Technology ...
InDevR Launches Expert Services to Address Vaccine Development Challenges
BOULDER, CO March 5, 2024 InDevR Inc., a global leader in vaccine analytical tools and method development, is excited to announce the launch of its latest offering, Expert Services. Expert ...
Webinar sponsored by bioMérieux — Next-Generation Rapid mRNA Vaccine CQA Analytics
In partnership with bioMérieux, InDevR's Erica Dawson, Ph.D., is presenting how the multiplex immunoassay platform, VaxArray, empowers Critical Quality Attribute (CQA) testing for multivalent mRNA vaccines. Analytical methods capable of ...
InDevR Raises $9 Million in Series B Financing and Partners with bioMérieux
Boulder, CO, 17 January 2023 – InDevR, Inc., a provider of best-in-class analytical technologies for vaccines and biotherapeutics, announced that it has raised $9 million in series B financing. Adjuvant ...
Vaccines Research & Development – November 7-9, 2022
InDevR will be presenting an Exhibitor Talk on November 7 at 12:50 - 1:00 pm ET. Speaker: April Blodgett To see our talk, visit the booth, and learn more about ...
Past News and Events
BOULDER, CO March 5, 2024 InDevR Inc., a global leader in vaccine analytical tools and method development, is excited to announce the launch of its latest offering, Expert Services. Expert Services provides vaccine manufacturers with tailored workflow solutions to help address and eliminate development bottlenecks and accelerate the analysis and ...
GEN Webinar: Speed and Simplicity for mRNA Vaccines and Therapeutics CQA Testing Register to view the webinar Speaker: Kathy Rowlen, PhD Title: CEO & Co-founder InDevR Bio: Dr. Kathy Rowlen has more than 20 years of management and research experience in business and academics, with more than 10 years in ...
CHI Webinar – Aug 25th, 2022: Assessing neuraminidase presence in influenza vaccines using InDevR’s VaxArray Platform Register to view the webinar Speaker: Jeff Pederson, Ph.D. Title: Global Head, Analytical Science and Technology, Seqirus Bio: Jeff Pederson is the Global Head, Analytical Science and Technology (AS&T) for Seqirus. He is responsible ...
InDevR Launches Highly Multiplexed Kit for Rapid Pneumococcal Vaccine Characterization BOULDER, Colo., May 10, 2022 (Newswire.com) - InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced the commercial availability of its VaxArray® Pneumococcal Assay Kit for rapid and accurate assessment ...
On-Demand WVC Webinar - May 10th, 2022: New CQA Test Kits for Multivalent Influenza Vaccines: 1 Hour Assay Provides Multiplexed Identity, Quantity, and Stability Testing We Invite you to our webinar on Tuesday May, 10th 2022 at 9:00 AM - 10:00 AM MDT Speaker: Dr. Erica Dawson Title: Chief Technology ...
World Vaccine Congress - April 18-21 2022 InDevR will be exhibiting and giving a short talk at the World Vaccine Congress. Talk Title: Identity, Quantity, and Integrity Characterization of Multivalent Vaccines from Bioprocess to Release Speaker: April Blodgett Title: Regional Sales Director Talk Date and time: April 20th 11:55 ...
